Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans?

Pharmacology and Therapeutics

Volumn 66, Issue 1, 1995, Pages 17-37

  Berendsen, H H G ^a  

^a NV ORGANON   (Netherlands)

Author keywords

5 HT uptake inhibitors; Depression 5 HT receptor subtypes receptor interactions receptor balance animal behaviour

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BEHAVIOR; BLOOD BRAIN BARRIER; DEPRESSION; DRUG RECEPTOR BINDING; HUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; HUMAN; RATS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0028935941     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(94)00075-E     Document Type: Review

References (184)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase
2. Blockade and reversal of 5-methoxy-N,N-dimethyltryptamineinduced analgesia following noradrenaline depletion
3. 2 agonist DOI
4. 2 binding sites in the frontal cortex of suicide victims and control subjects
5. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors
6. 8-Hydroxy-2-(di-n-propylamino)tetralin a new centrally acting 5-hydroxytryptamine receptor agonist
7. Long-term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats
8. Food intake, neuroendocrine and temperature effects of 8-OH-DPAT in the rat
9. Head-twitch response induced by ergometrine in mice: behavioural evidence for direct stimulation of central 5-hydroxytryptamine receptors by ergometrine
10. Penile erections in rats after fenfluramine administration
11. Denervation supersensitivity to 5-hydroxytryptophan in rats following spinal transection and 5,7-dihydroxytryptamine injection
12. “Wet-dog” shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity
13. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serolonin neurons
14. IB receptor mediation
15. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice
16. ID-like receptor involved in serotonergic induced hindlimb scratching in rats
17. Age dependence of 5-methoxytryptamine induced hindlimb scratching in rats
18. IC receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists antagonists or antidepressants
19. Comparison of the stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure
20. Mianserin affects thermoregulation bimodally via 5-HT and Na
21. IA receptors induces lower lip retraction in the rat
22. Functional interplay of serotonin (5-HT) receptor subtypes
23. Antagonism of 8-OH-DPAT-induced behaviour in rats
24. IC-receptors in drug-induced penile erections in rats
25. 2 receptor activation in rats
26. Role of dorsal and median raphe nuclei in lower lip retraction in rats
27. IA receptor-mediated spontaneous tail-flicks in the rat
28. 2 receptor binding on blood platelets—a peripheral marker for depression?
29. 2 receptor binding on blood platelets as a state dependent marker in major affective disorder
30. 2 receptor binding on blood platelets of suicidal men
31. Serotonin receptor sensitivity after acute and chronic treatment with mianserin
32. 2 binding site after chronic administration of agonists and antagonists
33. Effects of serotonergic lesion on “anxious” behavior measured in the elevated plus-maze test in the rat
34. 2 receptor binding in rat brain
35. 2 receptors
36. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: a physiological and pharmacological investigation
37. The effect of intravenous l-tryptophan on prolactin and growth hormone and mood in healthy subjects
38. 2 receptor down-regulation by amitriptyline
39. Central serotonin-like activity of 6-chloro-2[1-piperazinyl]-pyrazine (CPP; MK 212)
40. IC receptors in rat choroid plexus
41. Characterisation of the mechanism by which purported dopamine agonists reduce spontaneous locomotor activity of mice
42. Behavioural reactivity following 5-MeODMT administration in 5,7-DHT pretreated killer rats
43. Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: interactions with reserpine
44. IA and 5-HT: receptors?
45. 2-receptor interactions
46. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and l-tryptophan or tranylcypromine and l-dopa to rats
47. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan
48. Low doses of the putative serotonin agonist 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) elicit feeding in the rat
49. Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
50. Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino)telralin (8-OH-DPAT)
51. Evidence that blockade of postsynaptic 5-HT receptors elicits feeding in satiated rats
52. Pharmacological analysis of shaking behaviour induced by enkephalins thyrotropin-releasine hormones or serotonin in rats: evidence for different mechanisms
53. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests
54. 2 receptors mediated discrete behaviors in the mongolian gerbil
55. Effects of imipramine and serotonin-2 agonists and antagonist on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation
56. IA receptors in rats
57. 2 receptor interaction
58. IB binding sites
59. 2 receptors throughout the rat central nervous system using quantitative autoradiography
60. Basic advances in serotonin pharmacology
61. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and feeding induced by 8-OH-DPAT
62. 2 receptors
63. 2 receptor mediated head-twitch behaviour following antidepressant treatment to mice
64. 1 function
65. 1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats
66. The pharmacology of the behavioural and hypothermic response of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
67. The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity
68. Antagonism of drug-induced yawning and penile erections in rats
69. Studies in vivo on the relationship between brain tryptophan brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and l-tryptophan
70. The pharmacology of the hypothermic response of rodents to 8-OH-DPAT administration and the effects of psychotropic drug administration on this response
71. The effects of drugs on serotonin-mediated behavioural models
72. Quipazine: its effect on rat brain 5-hydroxytryptamine metabolism monoamine oxidase activity and behaviour
73. 2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated elctroconvulsive shock administration to rats
74. IA receptors
75. Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins and the long term effects of antidepressants on β-adrenoceptors and 5-HT binding in the rat cerebral cortex
76. IB receptor binding sites in brain?
77. ID receptors genes
78. 2 receptors
79. Monoamine-related markers of depression changes following treatment
80. Behavioural effects and brain amine content in rats
81. 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes
82. Hypothermia in the rat induced by the potent serotonergic agent 8-OH-DPAT
83. 8-Hydroxy-2-(di-n-propyalmino)tetralin, 8-OH-DPAT a potent and selective simplified ergo congener with central 5-HT receptor stimulating activity
84. Mianserin in out-patients with depressive illness in dosage up to 130 mg daily
85. 1 recognition sites
86. 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues
87. 5-HT receptors: subtypes and second messengers
88. A proposed new nomenclature for 5-HT receptors
89. Neurochemical and behavioural evidence for an agonist action of 1-[2(4-aminophenyl)ethyl]-4-(3-trifluoromethyl-phenyl) piperazine (LY 165163) at central 5-HT receptors
90. Acute versus chronic effects of serotonin uptake blockers on potentation of the “serotonin syndrome”
91. Serotonin-selective antidepressants
92. Brainstem and spinal cord mediation of a serotonergic behavioral syndrome
93. The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals
94. Discriminative stimulus properties of 8-OH-DPAT in rats are not altered by pretreatment with para-chlorophenylalanin
95. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain
96. Effects of housing restraint and chronic treatments with mCPP and sertraline on behavioural response to mCPP
97. IA function in young rats
98. IC receptors
99. IB receptors
100. IB agonists induce anorexia at a postsynaptic site
101. IC sites mediated the hypophagia in rats
102. Scratching response induced in mice by mescaline and related amphetamine derivates
103. Effect of apomorphine a dopamine receptor agonist, on penile tumescence in normal subjects
104. Apomorphine-induced penile tumescence in impotent patients—preliminary findings
105. IA receptor activation in humans
106. 2 (S2) receptor binding sites: Effects of neuronal lesions
107. Antidepressant specificity in atypical depression
108. IA receptor agonist Bay Vq 7813, in the pig
109. Changes in behavior associated with serotonin receptors following repeated treatment with antidepressant drugs
110. Reduction of feeding behaviour by the serotonin uptake inhibitor sertraline
111. Effects of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethyl-phenyl)piperazine on locomotor activity
112. 1 receptors
113. 3H] 5-hydroxytryptamine (5-HT) binding to brain stem preparations and the production and prevention of myoclonus in guinea pig by 5-HT agonists and antagonists
114. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims
115. Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies
116. Clinical and experimental aspects of interactions between amine opxidase inhibitors and amine uptake inhibitors
117. Regional serotonin receptor studies: chronic methysergide treatment induces a selective and dose-dependent decrease in serotonin-2 receptors in mouse cerebral cortex
118. Predictive value of symptoms of atypical depression for differential drug treatment outcome
119. 2 receptors in rat brain
120. Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: a comparison with haloperidol
121. IA receptor mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance
122. Role of serotonin in depression
123. 2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients
124. IA receptors and the tailflick response I
125. IA receptor
126. IA agonist and antagonists
127. IA receptor antagonist (S)-UH-301 in rodents and monkeys
128. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self stimulation behavior in rats
129. IC receptor activation in rats
130. Neuroendocrine effects of m-chlorophenylpiperazine a serotonin agonist in humans
131. Further studies of the putative serotonin agonist m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans
132. Phenyclindine-induced head-weaving observed in mice after ritanserin treatment
133. Effects of reserpine para-chlorophenylalanine, 5,6 dihydroxy-tryptamine and fludiazepam on head twitches induced by 5-hydroxytryptamine or 5-methoxytryptamine in mice
134. Biochemical and pharmacological characterisation of CGS 12066B a selective serotonin-IB agonist
135. IA receptor ligand, stereospecifically increases food intake
136. 1 receptors
137. The symptoms of major depression
138. Increased behavioural response to 5-methoxy-N,N-dimethyltryptamine but not to Ru 24969 after intraventricular 5,7-dihydroxytryptamine administration
139. Effects of 5,7-dihydroxytryptamine and 6-hydroxydopamine on head-twitch response induced by serotonin p-chloroamphetamine and tryptamine in mice
140. Treatment of seasonal affective disorder with d-fenfluramine
141. Platelet serotonin-2 receptor binding sites in depression and suicide
142. Cyproheptadine: weight gain and appetite stimulation in essential anorexic adults
143. The binding of serotonergic ligand to the porcine choroid plexus; characterization of a new type of serotonin recognition site
144. Two distinct central serotonin receptors with different physiological functions
145. IC/ID receptor agonists produce reciprocal effects on male sexual behavior of rhesus monkeys
146. Beneficial sexual side-effects from fluoxetine
147. IC receptors in the behavioural effects of the 5HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI)
148. IC receptor agonists and antagonist
149. Tertatolol, a new β-blocker, is a serotonin (5-hydroxytryptamineIA) receptor antagonist in rat brain
150. IA receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat
151. Monoamine oxidase inhibitors. A review of antidepressants effectiveness
152. Long lasting supersensitivity of 5-HT mediated behaviour following monoamine depletion in the rat brain
153. Reversible loss of nocturnal penile tumescence during depression: a preliminary report
154. Down regulation of serotonin 2 but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin 2 and beta-adrenergic receptors
155. 2 properties of derivatives of the hallucinogen 1-(2,5-dimethoxy-phenyl)-2-aminopropane (2,5-DMA)
156. 8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition
157. Lisuride and LSD: dopaminergic and serotonergic interaction in the “serotonergic syndrome”
158. Moclobemide: placebo controlled trials
159. Serotonergic mechanisms in human feeding: the pharmacological evidence
160. The effect of cyproheptadine on hunger calorie intake and body weight in man
161. IA receptor blockade increases penile erections induced by indirect serotonin agonists
162. Increased serotonergic-2 binding sites in frontal cortex of suicide victims
163. Effects of serotonergic agonists on micturition and sexual function in the rat
164. Effects of fenfluramine m-chlorophenyl-piperazine and other serotonin-related agonists and antagonists on penile erections in non human primates
165. Nocturnal penile tumescence in depressed men
166. Radioligand binding evidence implicate the brain 5HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens
167. 1 receptor and of catecholamine systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat
168. Subtypes of the 5HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat
169. Behavioural evidence for the rapid release of CNS serotonin by PCAand fenfluramine
170. Behavioural evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine
171. Serotonin precursors in the treatment of depression
172. Head twitches induced by LSD and quipazine similarities and differences
173. Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs
174. REM sleep reduction effects on depression syndromes
175. A comparison of the acute effects of dextro-amphetamine and fenfluramine in depression
176. Antidepressants and serotonergic neurotransmission: an integrative review
177. Reduction of sucrose preference by chronic unpredictable mild stress and its restoration by a tricyclic antidepressanl
178. IA agonist ipsapirone in non-fasted rats
179. The behavioural effects of intravenously administered tryptamime in mice
180. The role of central serotonergic mechanisms on head-twitches and backward locomotion induced by hallucinogenic drugs
181. 2 in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat
182. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shakes response in rats
183. Tryptophan depletion causes a rapid lowering of mood in normal subjects